Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108
Status:
RECRUITING
Trial end date:
2027-09-15
Target enrollment:
Participant gender:
Summary
The study looks at the safety and blood levels of the study drug INV-347 in participants who were previously dosed with INV-347 in study INV-CL-108. Participants will not get any study drug in this study as it looks into the safety of a drug previously dosed. The study will last for about 2 years.